The research team is now taking the steps necessary for making the promising drug available on the commercial market at the earliest date possible.
iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.
A team of researchers led by Osaka University Professor Koji Nishida has successfully treated an eye disease patient by transplanting artificially-cultured corneal cells derived from...
By Ikuro Beppu How exactly did Naomi Osaka feel right after winning the U.S. Open Grand Slam tennis championship by defeating Serena...
Gustav Strandell I still remember my first research trip to a nursing home in Japan. It was in 1997 in the Hokkaido countryside,...
Professor Shinya Yamanaka of Kyoto University, 55, became more widely known after he was awarded the Nobel Prize in Physiology or Medicine in 2012. Five...
